Michael Trauner
Impact in
- Hepatology top 0.01%
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Liver physiology and pathology
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 0.1%
- Drug Transport and Resistance Mechanisms
Papers in
- Hepatology 518
- Liver Disease and Transplantation 224
- Liver Diseases and Immunity 144
- Liver physiology and pathology 65
- Hepatitis C virus research 63
- Hepatocellular Carcinoma Treatment and Prognosis 51
- Oncology 194
- Drug Transport and Resistance Mechanisms 145
- Colorectal Cancer Screening and Detection 35
- Co-authors
- Peter Fickert (116 shared papers)Martin Wagner (51 shared papers)Gernot Zollner (60 shared papers)Thomas Reiberger (251 shared papers)James Lorenzen Boyer (16 shared papers)Emina Halilbasic (80 shared papers)Philipp Schwabl (124 shared papers)Marco A. Arrese (12 shared papers)
- Journals
- Journal of Hepatology (163 papers)Hepatology (70 papers)Liver International (60 papers)Alimentary Pharmacology & Therapeutics (34 papers)Gastroenterology (30 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Michael Trauner
946 papers receiving 53.7k citations
Michael Trauner's Hit Papers
Peers
Comparison fields: 5 of 181
- Hepatology 18.3k
- Oncology 9.9k
- Epidemiology 11k
- Pharmacology 3k
- Pollution 1.5k
Countries citing papers authored by Michael Trauner
This map shows the geographic impact of Michael Trauner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Trauner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Trauner more than expected).
Fields of papers citing papers by Michael Trauner
This network shows the impact of papers produced by Michael Trauner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Trauner. The network helps show where Michael Trauner may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Trauner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Detection of Various Microplastics in Human Stool Hit paper breakdown → | 2019 | 1590 |
| 2 | Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) Hit paper breakdown → | 2016 | 1100 |
| 3 | Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial Hit paper breakdown → | 2019 | 1078 |
| 4 | A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis Hit paper breakdown → | 2016 | 919 |
| 5 | Bile Salt Transporters: Molecular Characterization, Function, and Regulation Hit paper breakdown → | 2003 | 823 |
| 6 | The interaction of hepatic lipid and glucose metabolism in liver diseases Hit paper breakdown → | 2011 | 810 |
| 7 | 2006 | 693 | |
| 8 | ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1 Hit paper breakdown → | 2011 | 661 |
| 9 | Advancing the global public health agenda for NAFLD: a consensus statement Hit paper breakdown → | 2021 | 600 |
| 10 | Bile acid receptors as targets for drug development Hit paper breakdown → | 2013 | 597 |
| 11 | 1998 | 595 | |
| 12 | 2020 | 593 | |
| 13 | Gut-liver axis: Pathophysiological concepts and clinical implications Hit paper breakdown → | 2022 | 585 |
| 14 | Bile acids and nonalcoholic fatty liver disease Hit paper breakdown → | 2016 | 541 |
| 15 | Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid Hit paper breakdown → | 2014 | 482 |
| 16 | 2011 | 478 | |
| 17 | Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2018 | 470 |
| 18 | 1997 | 449 | |
| 19 | 2015 | 442 | |
| 20 | Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis Hit paper breakdown → | 2017 | 417 |
About Michael Trauner
Michael Trauner is a scholar working on Hepatology, Oncology, Epidemiology, Surgery and Pharmacology, having authored 1k papers that have together received 55.1k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (224 papers), Liver Disease Diagnosis and Treatment (194 papers), Drug Transport and Resistance Mechanisms (145 papers), Liver Diseases and Immunity (144 papers), Liver physiology and pathology (65 papers), Hepatitis C virus research (63 papers), Hepatocellular Carcinoma Treatment and Prognosis (51 papers) and Colorectal Cancer Screening and Detection (35 papers). The work is most often cited by research in Hepatology (18.3k citations), Oncology (9.9k citations), Epidemiology (11k citations), Pharmacology (3k citations) and Pollution (1.5k citations). Michael Trauner has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Peter Fickert, Martin Wagner, Gernot Zollner, Thomas Reiberger, James Lorenzen Boyer, Emina Halilbasic, Philipp Schwabl, Marco A. Arrese, Peter L. M. Jansen and Claudia Daniela Fuchs. Their work appears in journals such as Journal of Hepatology, Hepatology, Liver International, Alimentary Pharmacology & Therapeutics and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.